Moderna’s coronavirus vaccine may be promising for elderly
We? On the search for a vaccine for covert 19 Yesterday, Moderna published findings that the elderly and their ongoing trials are releasing more and stronger antibodies, and they thought they would Matt Harper has been taking a look at vaccines for partners that stat health medicine publication. He joins us now and Matt. Let's just go broader here. We've been hearing from President Trump that the vaccine will be ready by mid October. What are the experts saying? Well, there is one vaccine that could potentially have data telling us that it works. And that's the Fizer vaccine. That's the on ly one that's in the October timeframe. Moderna has said that They're looking at late November. Even if that happens, approval or even emergency use authorization may not be instantaneous. And distribution will not be Instantaneous, which is what Chris Wallace was trying to ask about during the debate the other night well and tell us who decides because we know the FDA made an announcement they were going to extend sort of the examination period of the results of the different companies. And President Trump said that that was political that they were just trying to hurt him and that he would be the one who decides But aren't there committees and commissions who actually have the final word on this? There is a worry that if they wanted to the administration could circumvent the entire FDA process. The much more likely scenario is that it will follow the normal process and that that has to go through the FDA and there is a committee. That the FDA convenes to get advice on the data before it makes a decision. You know, the companies hire these outside committees that watch over the studies, and those are the ones that would tell you at this point that the data from these vaccines are so good. That you're going to find out about them. Now it could take several months for us to get the data from the Madonna and Fizer vaccines. If wonderfully, there were fewer cases of covert around, but also if the vaccines turned out to be less effective than hoped. And just briefly. We know there are some top contenders for some of the first vaccines and they're in different stages, but most of them are pretty far in Into their testing. So what is left to be done to show that a vaccine is safe? So you have to show First of all that you're reducing the number of cases of symptomatic Cove it people who test positive for the virus and have symptoms and you have to show that There are fewer cases in the group of people who got the vaccine and the people who got the placebo. Some of the trials are saying they want at least two months of follow up on half the patients in the trial, and that's because most vaccine side effects would happen within that time frame. And part of the worries if you stop early, but you don't have enough data in the elderly and you don't have enough data in adolescence, then you might not have of those data ever if somehow releasing the first day that causes there to be issues with the trial. Ongoing visor says that they plan to keep their trial on going past the first analyses. But that's basically what has to happen. The vaccines have to actually prove that they work and prove that they are safe. A lot of the people who say to wait. Some of the critics are basically saying it's not that big a wait to get a lot more information right?